Hossien Parsa1, Simin Samani2. 1. Department of Vascular Surgery, Qazvin University of Medical Sciences, Qazvin, Iran. 2. Department of Pathology, Qazvin University of Medical Sciences, Qazvin, Iran.
Abstract
INTRODUCTION: Approximately 25% of people with diabetes will experience diabetic foot ulcers (DFUs) during their lifetime. The present study was designed to evaluate the prevalence of diabetic foot infection among patients with DFUs and to identify the microorganisms isolated from the DFUs. This study also aimed to determine predisposing factors contributing to these infections at the authors' wound care clinic at the Rajaii and Velayat University Hospitals in Qazvin, Iran. METHODS: This cross-sectional descriptive study included 500 patients with diabetes mellitus between May 2011 and April 2013 at the authors' wound care clinic in Qazvin, Iran. All demographic, clinical, and laboratory data such as age, sex, duration of diabetes (years), duration of DFUs before inclusion in the study, size of ulcer (cm2), glycosylated hemoglobin (HbA1c), and results of ulcer culture were collected for each case. The collected data were analyzed using SPSS software (SPSS Inc, Chicago, IL). A P value less than 0.05 was considered significant. RESULTS: Overall, 54 (11%) patients with infected ulcers were found in the present study. Among patients with infected DFUs, the most commonly isolated microorganism was Pseudomonas aeruginosa, which infected 35% of patients, followed by Staphylococcus aureus in 19% of patients, and methicillin-resistant S. aureus in 6% of patients. Additionally, in the multivariable logistic regression model, age > 65 years, ulcer size > 2 cm2, and HbA1c > 7% were associated with the occurrence of an infection in DFUs. CONCLUSION: Periodic examination of the feet of patients with diabetes is necessary. In addition, to decrease the prevalence of infected DFUs, more attention to the described risk factors is recommended.
INTRODUCTION: Approximately 25% of people with diabetes will experience diabetic foot ulcers (DFUs) during their lifetime. The present study was designed to evaluate the prevalence of diabetic foot infection among patients with DFUs and to identify the microorganisms isolated from the DFUs. This study also aimed to determine predisposing factors contributing to these infections at the authors' wound care clinic at the Rajaii and Velayat University Hospitals in Qazvin, Iran. METHODS: This cross-sectional descriptive study included 500 patients with diabetes mellitus between May 2011 and April 2013 at the authors' wound care clinic in Qazvin, Iran. All demographic, clinical, and laboratory data such as age, sex, duration of diabetes (years), duration of DFUs before inclusion in the study, size of ulcer (cm2), glycosylated hemoglobin (HbA1c), and results of ulcer culture were collected for each case. The collected data were analyzed using SPSS software (SPSS Inc, Chicago, IL). A P value less than 0.05 was considered significant. RESULTS: Overall, 54 (11%) patients with infected ulcers were found in the present study. Among patients with infected DFUs, the most commonly isolated microorganism was Pseudomonas aeruginosa, which infected 35% of patients, followed by Staphylococcus aureus in 19% of patients, and methicillin-resistant S. aureus in 6% of patients. Additionally, in the multivariable logistic regression model, age > 65 years, ulcer size > 2 cm2, and HbA1c > 7% were associated with the occurrence of an infection in DFUs. CONCLUSION: Periodic examination of the feet of patients with diabetes is necessary. In addition, to decrease the prevalence of infected DFUs, more attention to the described risk factors is recommended.
Authors: Cassandra E Nelson; Weiliang Huang; Luke K Brewer; Angela T Nguyen; Maureen A Kane; Angela Wilks; Amanda G Oglesby-Sherrouse Journal: J Bacteriol Date: 2019-05-22 Impact factor: 3.490
Authors: Ilker Uçkay; Dan Lebowitz; Benjamin Kressmann; Elodie von Dach; Benjamin A Lipsky; Karim Gariani Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2022-05-23
Authors: Minfeng Wu; Yan Li; Dongjie Guo; Gang Kui; Bin Li; Yu Deng; Fulun Li Journal: Evid Based Complement Alternat Med Date: 2018-07-09 Impact factor: 2.629